Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.936 EUR | -1.78% |
|
+44.89% | +9.99% |
27/03 | Nextedia S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Nextedia S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Its low valuation, with P/E ratio at 9 and 6.75 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company shows low valuation levels, with an enterprise value at 0.29 times its sales.
- The company has a low valuation given the cash flows generated by its activity.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.99% | 22.55M | - | ||
-13.46% | 192B | A- | ||
+1.65% | 166B | B+ | ||
+5.25% | 159B | B- | ||
+2.34% | 102B | A- | ||
+49.35% | 94.12B | C- | ||
+15.88% | 85.34B | A- | ||
-0.14% | 76.53B | A | ||
-1.53% | 47B | A- | ||
-34.61% | 41.59B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ALNXT Stock
- 0CZ7 Stock
- Ratings NEXTEDIA